EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Identification and Functional Characterization of a Novel De Novo SATB1 Frameshift Variant in a Patient with Epilepsy-Dominant Neurodevelopmental Disorders

Mingchao Xu iD, Rui Zhang, Shiqi Fan iD, Miao Sun, Xue Zhang

Genes · 15.05.2026 · 17 (5) · 565

DOI: 10.3390/genes17050565 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, online erschienen am 15.05.2026. Verfasst von Mingchao Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: McKusick-Zhang Center for Genetic Medicine, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Epilepsy, Frameshift Mutation, Matrix Attachment Region Binding Proteins, Neurodevelopmental Disorders. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: As a global chromatin organizer, SATB1 is increasingly implicated in neurodevelopmental disorders (NDDs). This study aims to delineate the clinical and molecular characteristics of a novel de novo SATB1 variant in a patient presenting with epilepsy-dominant NDDs phenotypes.

Methods

Triggered by the onset of seizures, trio-based whole-exome sequencing (Trio-WES) was performed to identify the genetic etiology. Subsequent sleep electroencephalogram (EEG) and magnetic resonance imaging (MRI) were then conducted to further characterize the patient’s clinical phenotypes. Pathogenicity was assessed through structural modeling and functional characterization. Nonsense-mediated mRNA decay (NMD) status, protein expression profiles, and subcellular localization were determined by reverse-transcription quantitative PCR (RT-qPCR), Western blotting, and immunofluorescence staining. The transcriptional regulatory impacts of the variant were quantified using dual-luciferase reporter system targeting known downstream regulatory elements. Clinical responses to antiepileptic intervention was also monitored.

Results

We identified a novel de novo heterozygous pathogenic frameshift variant in SATB1 (NM_002971.5: c.1718_1719insCA; p.Val574Argfs*134) in a patient presenting with early-onset epilepsy, mild intellectual developmental disorder (IDD), speech delay, and dental anomalies. Functional assays demonstrated that the variant-derived transcript escaping NMD, yielding a truncated protein that forms irregular punctate aggregates within nuclei. Dual-luciferase assays revealed significantly increased transcriptional activity, indicating a loss of the protein’s innate transcriptional regulatory capacity. Clinically, treatment with sodium valproate (VPA) successfully stabilized seizures of the patient, markedly reducing both frequency and intensity.

Conclusions

The study reports a novel SATB1 frameshift variant that exerts pathogenicity significant functional impairment by disrupting protein localization and transcriptional regulation. These findings expand the genetic spectrum of SATB1-related NDDs and underscore the efficacy of targeted antiepileptic management in genetic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyFrameshift MutationMatrix Attachment Region Binding ProteinsNeurodevelopmental DisordersHumansMaleExome SequencingNonsense Mediated mRNA DecayPhenotypeChild, Preschool

Stichwörter der Autor:innen

SATB1de novo variantepilepsyframeshift variantgenotype-phenotype correlationneurodevelopmental disordersnonsense-mediated mRNA decay (NMD)truncated protein

Substanzen

Matrix Attachment Region Binding ProteinsSATB1 protein, human

Autor:innen und Institutionen

  • McKusick-Zhang Center for Genetic Medicine, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, No.5 Dongdan Santiao, Dongcheng District, B…
  • State Key Laboratory for Complex Severe and Rare Diseases, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, No.5 Dongdan Santiao, Dongch…

ORCID-Profile: Mingchao Xu, Shiqi Fan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Xu, M., Zhang, R., Fan, S., Sun, M., & Zhang, X. (2026). Identification and Functional Characterization of a Novel De Novo SATB1 Frameshift Variant in a Patient with Epilepsy-Dominant Neurodevelopmental Disorders. Genes, 17(5), 565. https://doi.org/10.3390/genes17050565

Vancouver

Xu M, Zhang R, Fan S, Sun M, Zhang X. Identification and Functional Characterization of a Novel De Novo SATB1 Frameshift Variant in a Patient with Epilepsy-Dominant Neurodevelopmental Disorders. Genes. 2026;17(5):565. doi:10.3390/genes17050565

BibTeX
@article{Xu2026,
  author = {Xu, Mingchao and Zhang, Rui and Fan, Shiqi and Sun, Miao and Zhang, Xue},
  title = {Identification and Functional Characterization of a Novel De Novo SATB1 Frameshift Variant in a Patient with Epilepsy-Dominant Neurodevelopmental Disorders},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {565},
  doi = {10.3390/genes17050565}
}
Kostenlos starten →